- Jul 30, 2007
- 8,367
- 68
- 0
- School/Org
- Newsbot U
- City
- Barre
- State
- VT
Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular ... (Business Wire via Yahoo! Finance)
Published: Fri, 03 Aug 2007 03:59:00 GMT
TARRYTOWN, N.Y. & LEVERKUSEN, Germany----Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG announced today that the companies have initiated a Phase 3 study of the VEGF Trap-Eye in the neovascular form of age-related macular degeneration .
Read More...
Published: Fri, 03 Aug 2007 03:59:00 GMT
TARRYTOWN, N.Y. & LEVERKUSEN, Germany----Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG announced today that the companies have initiated a Phase 3 study of the VEGF Trap-Eye in the neovascular form of age-related macular degeneration .
Read More...
